|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.8 TWD | -0.50% |
|
-1.00% | -21.74% |
| 15/04 | Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only | CI |
| 21/03 | Applied BioCode Announces CEO Changes | CI |
Applied BioCode Corporation announced appointment of Liang-Kai (Jaca) Huang/CFO of the Company as Corporate Governance Officer. Type of the change: New replacement. Reason for the change: Appointment of a corporate governance officer according to the regulation.
Effective date is March 13, 2023. Any other matters that need to be specified: The board of directors resolved that Jaca Huang, the CFO, should double as the corporate governance officer.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.74% | 50.18M | |
| -27.01% | 10.26B | |
| +31.86% | 3.04B | |
| -8.58% | 2.94B | |
| -13.62% | 2.19B | |
| -16.32% | 1.72B | |
| +63.36% | 1.4B | |
| +27.00% | 780M | |
| -2.18% | 736M | |
| -19.18% | 560M |
APPLIED BIOCODE CORPORATION 
